Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7323015 | 0.77 | MAPT (0.46) | ALDH1A1MAPTGAAMDM2SMN1; SMN2 | |
| SCHEMBL11754489 | 0.72 | MAPT (0.36) | ALDH1A1MAPTGAAMDM2SMN1; SMN2 | |
| SCHEMBL9762507 | 0.72 | MAPT (0.39) | ALDH1A1MAPTGAAMDM2SMN1; SMN2 | |
| SCHEMBL29105506 | 0.72 | MAPT (0.36) | ALDH1A1MAPTGAAMDM2SMN1; SMN2 | |
| SCHEMBL11077687 | 0.69 | ALDH1A1 (0.34) | ALDH1A1MAPTGAAMDM2SMN1; SMN2 | |
| SCHEMBL29105514 | 0.69 | GFER (0.35) | ALDH1A1MAPTGAAMDM2SMN1; SMN2 | |
| SCHEMBL29105510 | 0.69 | ALDH1A1 (0.41) | ALDH1A1MAPTGAAMDM2SMN1; SMN2 | |
| SCHEMBL5182827 | 0.68 | MAPT (0.40) | ALDH1A1MAPTGAAMDM2SMN1; SMN2 | |
| SCHEMBL11347718 | 0.68 | ALDH1A1 (0.37) | ALDH1A1MAPTGAAMDM2SMN1; SMN2 | |
| SCHEMBL9762410 | 0.66 | ALOX15 (0.42) | ALDH1A1MAPTGAAMDM2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0697022-A1 | PHOSPHORAMIDATES USEFUL AS ANTITUMOR AGENTS | Research Corporation Technologies, Inc (US) | 1996-02-21 | — | — | EP | disclosed |